Stockreport

Shareholder Alert: Ademi LLP Investigates Whether Lumos Pharma, Inc. Is Obtaining a Fair Price for Its Public Shareholders

Lumos Pharma, Inc.  (LUMO) 
PDF MILWAUKEE--(BUSINESS WIRE)--Ademi LLP is investigating Lumos Pharma (NASDAQ: LUMO) for possible breaches of fiduciary duty and other violations of law in its transac [Read more]